DNTTIP1/2 & low-grade glioma patients
This study demonstrated that DNTTIP1/2 had diagnostic and prognostic value in low-grade glioma patients.
Stay updated with breaking news from Gene Set Variation Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This study demonstrated that DNTTIP1/2 had diagnostic and prognostic value in low-grade glioma patients.
Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2021 News provided by Share this article SAN DIEGO, March 10, 2021 /PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company developing drugs to treat cancers with the greatest medical need for new treatment options, including KRAS-mutated colorectal cancer, pancreatic cancer, castrate-resistant prostate cancer and leukemias, today announced the publication of two abstracts that will be presented as electronic posters during Week 1 of the American Association for Cancer Research ...